Lubris BioPharma is a biopharmaceutical company developing recombinant human lubricant for the treatment of dry eye, osteoarthritis and other age & inflammation-related conditions.
|
Jupiter Orphan Therapeutics, Inc. (JOT) is a clinical stage specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT has developed a unique formula, JOTROL™, which is a unique formulation of Resveratrol.
|
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that has acquired certain rights to, and is developing, NACA, a small molecule antioxidant for the treatment of retinitis pigmentosa and potentially other retinal-based diseases.
|
Inversago Pharma Inc. is focused on the development of peripherally-restricted CB1 receptor (CB1) inverse agonists for the treatment of Prader-Willi syndrome, type 1 diabetes and metabolic disorders in general.
|
Proudly powered by Weebly